QAi Prostate Grade Receives Class C IVD Approval from Singapore’s Health Sciences Authority

Singapore, Aug 5, 2025 — Qritive is proud to announce that its AI-powered diagnostic solution, QAi Prostate Grade, has received Class C In Vitro Diagnostic (IVD) registration from Singapore’s Health Sciences Authority (HSA), following a comprehensive premarket evaluation.

This regulatory approval paves the way for clinical adoption of QAi Prostate Grade in pathology laboratories across Singapore, enabling pathologists to enhance prostate cancer diagnostics with AI-driven clinical decision support.

Aligned with Singapore’s Vision for Digital Health Innovation

This achievement reflects Singapore’s continued commitment to integrating safe, effective, and vendor-neutral innovations into clinical practice. QAi Prostate Grade is designed to integrate seamlessly with existing image management systems, allowing flexible deployment without the need for costly infrastructure changes.

The approval by HSA — an authority recognized globally for its rigorous and internationally aligned evaluation standards — affirms Qritive’s dedication to clinical safety, performance, and regulatory compliance.

Empowering Pathologists with Scalable, AI-Powered Solutions Abu

Singapore represents a key market for Qritive in the Asia-Pacific region, and this approval strengthens our ability to deliver scalable, clinically validated AI solutions that support early detection, improve diagnostic consistency, and streamline pathology workflows.

See the Impact 

Below are sample visuals from the QAi Prostate Grade module, showing original pathology slides alongside AI-assisted grading outputs — demonstrating how the solution can support pathologists in clearly detecting and grading prostate cancer. 

Without AI Overlay

With QAi Prostate Grade Overlay

About Qritive

Headquartered in Singapore, with operations in the US and India, Qritive is a breakthrough Artificial Intelligence (AI) solution developer that is advancing digital pathology for cancer diagnosis and improving health outcomes. Qritive leverages deep learning technology to support the interpretation of pathology tests for time and resource-strapped pathologists, enabling faster diagnosis and reducing time to treatment for patients. Qritive is dedicated to empowering healthcare professionals across the globe with AI-powered solutions to operate collaboratively at the peak of their performance despite complexity and distance. 

Get in Touch

Want to learn more about our solutions or explore potential collaborations?

Visit www.qritive.com or contact us at info@qritive.com